Patent · US Expired

Treatment of prostate cancer

US7378445B2 · kind B2 · utility

5Cited by
18References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 3, 2006
Grant dateMay 27, 2008
Priority date
Expiry dateJan 3, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A chemical agent of the diterpene family obtained from a member of the Euphorbiaceae family of plants for use in the treatment of prophylaxis of prostate cancer or a related cancer or condition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.